Stem Cells, Cellular Therapeutics and Regenerative Medicine - The Online Scientific Community

This website and its affiliated micro-sites are owned and published by Technology Networks Ltd.

To ensure that you get the most from our website, we are committed to optimizing the site to match your needs, so it is easier for you to find the content and services most relevant to your work and keeping access to most of our content and services free of charge. We endeavour to exceed the strict privacy practices required by the United States CAN-SPAM Act of 2003, the United Kingdom Data Protection Act and the 2002 European Directive on Privacy and Electronic Communications. If, however, you would like to make a query regarding our privacy policy please contact us.

Information we collect from you

Site visitors are required to complete a registration process. By registering, visitors provide us with information about who they are, the work they do, and their interests. Once registration is complete no further information of this sort is required for free access to this site. Further personal information from visitors may be required to participate in the online Forums. We may also collect information regarding your use of the websites by monitoring the use of cookies.

How we use Personal Information The information that we gather is used in a variety of ways. The first is to build up a demographic profile of our membership, allowing us to better match our content and services to the interests of our members. Obviously, the more accurate the information provided by each member, the better we can do this. For this reason, visitors are encouraged to regularly update their profiles to provide us with the most accurate information possible.

We may disclose your information to other companies in order to ensure the smooth provision of services that you have booked with us. If you have made a booking with us your data will be principally used to provide you with your purchase as well as your registration or other services and facilities.

Your details may be shared within the Technology Networks and Select Biosciences group. Please click here for a list of websites and company details. These companies may use your details to send you information about products, promotions and special offers that we think may interest you.

The information is also used in our dealings with the third parties with whom we work. The co-operation of the companies that supply us with content and services and the revenue derived from advertising and sponsorship allow us to keep access to our sites free of charge. In order to provide incentives for these third parties to continue working with us, Technology Networks Ltd. does share some information about our visitors, as detailed below.

We may monitor the activity of visitors accessing the site and share data about this activity with publishers and advertisers. However, personal data about an individual member is only provided to third parties if the visitor has given us prior consent to do so by ticking the relevant box in our registration form.

Personal data about individual members is never shared with a third party we do not consider to be reputable and is only made available to companies who are actively supporting free access to the content and services provided by our sites. Visitors should note however that, if they enter another site from a link within a Technology Networks Ltd. site, they are no longer covered by this privacy policy.

How you can access and update your data

We have designed our websites so that it is easy for you to access and update the personal information that you saved with us. After you log in you will be provided with a link that will allow you to access and update your details. Individual eNewsletters can be immediately unsubscribed by clicking an unsubscribe link within them. If you require further assistance on updating your details please contact us.

Changes to this policy If at any point we decide to use your personally identifiable information in any way other that described in this privacy policy we will notify you by way of email or by 30 days notice on the website. Please note that we retain the right to change this policy at any time. Technology Networks Ltd. continues to invest in the best quality security available and we do our utmost to protect visitor privacy. If you have any queries regarding this privacy policy or the way we collect and gather information about our members, please e-mail your comments and questions to support@technologynetworks.com

New Technique Reveals Unseen Information in DNA Code
Scientists have developed and tested a technique to distinguish between two modified forms of cytosine.

World's First Approved Stem Cell Drug
Osiris Receives Marketing Clearance from Health Canada for Prochymal. Historic decision offers hope to children suffering from life-threatening GvHD.

Genetic Packing: Successful Stem Cell Differentiation Requires DNA Compaction, Study Finds
New research findings show that embryonic stem cells unable to fully compact the DNA inside them cannot complete their primary task: differentiation into specific cell types that give rise to the various types of tissues and structures in the body.

Promethera Biosciences Treats First Patients with Promethera® HepaStem
Phase I/II study designed to evaluate the ability of liver progenitor cells to restore a missing enzyme function in liver-based metabolic diseases.

New Muscular Dystrophy Treatment Approach Developed Using Human Stem Cells
New process makes the production of human muscle cells from stem cells efficient and effective.

Duke Team Turns Scar Tissue into Heart Muscle Without Using Stem Cells
Scientists at Duke University Medical Center have shown the ability to turn scar tissue that forms after a heart attack into heart muscle cells using a new process that eliminates the need for stem cell transplant.

“Housekeeping” Mechanism for Brain Stem Cells Discovered
Researchers at Columbia University Medical Center (CUMC) have identified a molecular pathway that controls the retention and release of the brain’s stem cells.

IBN Discovers Human Neural Stem Cells with Tumor Targeting Ability
The discovery is promising for the future of breast cancer therapy.

Researchers Derive Purified Lung and Thyroid Progenitors from Embryonic Stem Cells
Research provides information about tissue engineering technology which can be used to develop new gene and cell-based therapies to treat lung diseases.

Oxygen Levels Do Not Determine Radiation Survival of Breast Cancer Stem Cells
Today, oxygen is recognized to be one of the most powerful radiation sensitizers. This study outlines research into how breast cancer stem cells are protected from radiation through expression of free radical scavengers, with little increase provided by hypoxia.